🇺🇸 FDA
Patent

US 10925923

Peptide having anti-inflammatory activity, and use thereof

granted A61KA61K38/07A61K38/08

Quick answer

US patent 10925923 (Peptide having anti-inflammatory activity, and use thereof) held by CAREGEN CO., LTD. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/07, A61K38/08, A61P, A61P29/00